Y-Intercept (HK)’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-83,864	Closed	-$117K	–	2022
2025 Q1	$117K	Buy	+83,864	New	+$117K	0.01%	1103
2024 Q2	–	Sell	-97,054	Closed	-$279K	–	1926
2024 Q1	$279K	Buy	+97,054	New	+$279K	0.02%	988